TREATMENT OF DISSEMINATED BREAST CANCER WITH TAMOXIFEN, AMINOGLUTETHIMIDE, HYDROCORTISONE, AND DANAZOL, USED IN COMBINATION OR SEQUENTIALLY

T.J. Powles, H.T. Ford, A G Nash, S. Ashley, J.-C. Gazet, A.M Neville, Alan Nevill, R. Charles Coombes
In: The Lancet · 1984 · vol. 323(8391) , pp. 1369–1373 · doi:10.1016/s0140-6736(84)91872-5 · PMID:6145832 · W2043855853
article OA: closed CC0 ⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper details the use of tamoxifen, aminoglutethimide, hydrocortisone, and danazol, alone or in sequence, for treating disseminated breast cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cited by (3)

References (19)

Cited by (3)

Source provenance

openalex
last seen: 2026-05-10T10:20:42.538694+00:00
License: CC0 · commercial use OK